MUC16 and neoplasm: revealed that in lung adenocarcinoma, a matrix metalloproteinase-resistant variant of MUC16 may lead to tumor cell evasion of the immune system, reducing tumor-specific peptide presentation through HLA-A and HLA-B molecules, thereby promoting tumor immune escape (106).